IndraLab

Statements

PBRM1 binds SETD2, BAP1, and KDM5C. 3 / 3
| 3
sparser
"We and others have reported the associations of PBRM1 , SETD2 , BAP1 , and KDM5C mutations with advanced stage, grade, and tumor invasiveness [ xref , xref ], and discovered that SETD2 and BAP1 mutations are associated with lower cancer-specific survival rates [ xref , xref ]."
25124064
sparser
"Mutations in PBRM1, SETD2, BAP1 , and KDM5C are associated with tumors of advanced stage (odds ratio range 2.34 to 6.40, 2.5, 2.62 to 4.57, 7.6, respectively)."
27104219
sparser
"Our study indicates that mutations of PBRM1 , SETD2 , BAP1 and/or KDM5C in kidney cancers are associated with advanced stage, grade and tumor invasiveness."
23036577